Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol.
Katie AndresenEmma CuttingDimitrios ApostolopoulosAmy H EvansLaura OakleyAlimu DayimuNikolaos DemirisKatherine BongaertsRobyn StaplesWendy GoodingDavid RubinszteinRoger A BarkerPublished in: BMJ open (2024)
EudraCT-2021-000897-27, ISRCTN56240656.